BARCELONA—A new pencil beam scanning proton delivery technique—rescanning—could help limit the dose of radiation to surrounding tissues and organs by compensating for tumor motion in the chest caused by breathing. Rosalind Perrin MD, from the Centre...
BARCELONA—A radiotherapy dose of more than 54 Gy improved survival in children with localized cerebral ependymoma in a large multicenter study from France that looked at the role of age, grade and dose on outcome in 177 patients over a period of 13...
VIENNA—Three key targetable pathways for breast cancer treatment were assessed at the St Gallen Breast Cancer Conference by Clifford Hudis, MD, Chief of the Breast Medicine Service at Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical...
VIENNA—Obesity and insulin resistance were named as important targets for primary prevention of breast cancer by Pamela J. Goodwin, MD, MSc, FRCPC, Professor of Medicine and Director of the Marvelle Koffler Breast Centre at the University of...
VIENNA—The bone microenvironment was regarded as a worthy target for breast cancer treatment in comments at the St Gallen Breast Cancer Conference from Michael Gnant MD, a Professor and Director of the Medical University of Vienna, who gave Oncology...
VIENNA—At the St Gallen Breast Cancer Conference BCL-2 was named as a therapeutic target for patients with hormone-receptor positive breast cancer by Geoffrey J Lindeman BSc(Med) PhD, from the University of Melbourne and the Walter and Eliza Hall...
VIENNA—Because harnessing the immune system is now proven as a way of managing breast cancer, clinicians should consider the role of tumor infiltrating lymphocytes, according to Giuseppe Curigliano MD PhD, Director of the Early Drug Development for...
VIENNA—Understanding the emerging genomic landscape of breast cancer needed international research including large molecular screening projects—according to Peter Campbell MD PhD, head of Cancer Genetics and Genomics at the Sanger Institute in...
VIENNA—With actionable genomic alterations already being targeted by some existing approved drugs in patients with breast cancer genomic analysis was being hailed at the St Gallen Breast Cancer Conference as a way to expand the range of...
VIENNA—For women with premenopausal breast cancer the benefits of using the most adjuvant endocrine treatment needs to be weighed against additional side effects—according to Marco Colleoni MD from the European Institute of Oncology in Milan. After...
VIENNA—Despite the proliferation of genetic tests for breast cancer recurrence risk these cannot yet reliably be used to predict late recurrences. So said Daniel Hayes MD, Clinical Director of the Breast Oncology Program at the University of...
VIENNA—Estrogen receptor negative breast cancer might be prevented by strategies under investigation including HER2-targeting, vaccination and treatment with metformin or retinoids. Powel Brown MD, Chairman of the Department of Clinical Cancer...